Screener
Phathom Pharmaceuticals, Inc. PHAT Q2 2026 earnings
Reported July 30, 2026 · Before market open
Revenue$74.3MBeat by $1.0M
EPS-$0.21Miss by $0.03
Revenue estimate$73.2M
EPS estimate-$0.18
Next report
Date not yet announcedValuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Phathom Pharmaceuticals, Inc. report Q2 2026 earnings?
- Phathom Pharmaceuticals, Inc. (PHAT) reported Q2 2026 earnings on July 30, 2026 before market open.
- What were Phathom Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
- Phathom Pharmaceuticals, Inc. reported revenue of $74.3M and eps of $-0.21 for Q2 2026.
- Did Phathom Pharmaceuticals, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $73.2M by $1.0M. EPS missed the consensus estimate of $-0.18 by $0.03.
- How did Phathom Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 88.0% from $39.5M a year earlier and eps grew 73.4% from $-0.79.
- Where can I find Phathom Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-324865) and the 10-Q periodic report (0001193125-26-324867) directly on SEC EDGAR. The filing index links above go to sec.gov.
